Curaleaf announces CBD consumer product line
Curaleaf, a vertically integrated United States cannabis operator, which Bloomberg reports is seeking a valuation of $4 billion, today announced the launch of a line of premium hemp-based CBD products.
The line, which is called Curaleaf Hemp, will include:
- Drops: CBD oil in droplet forms mixed with natural essential oils (available in Lemon Bergamot, Lavender Sweet Orange, Ginger Clove Cinnamon, Vanilla Ylang Ylang and Jasmine Wintergreen)
- Lotions: Topical cream for everyday pain relief (available in Lemongrass and Menthol)
- Soft-Gel Capsules: Convenient capsules for daily use
- Disposable Vape Pens: On-the-go vape pens (available in Lemon Bergamot, Lavender Sweet Orange, Ginger Clove Cinnamon, Vanilla Ylang Ylang and Jasmine Wintergreen)
“Expanding our presence within the industry and entering the consumer goods marketplace with Curaleaf Hemp is an exciting step for the company,” said Joe Lusardi, President and Chief Executive Officer of Curaleaf. “Patients already trust and rely on Curaleaf for the highest-quality medical cannabis products and we have taken that same care with the development of Curaleaf Hemp. Supporting overall wellness, Curaleaf Hemp is a consistent and reliable line of hemp-based CBD products that consumers can trust. We expect this to become a significant economic contributor to our business in the years to come.”
All CBD used in Curaleaf products comes from hemp plants grown in Kentucky and Colorado.